Press Releases

NEW YORK, Aug. 19, 2019 /PRNewswire/ -- HOLISTIK Wellness LLC, a start-up health and wellness company born from the inspiration to utilize the entire hemp plant to help consumers live more holistically, today announced the release of an innovative new CBD product – the HOLISTIK™ Stir STIK™.

PLYMOUTH MEETING, Pa., Aug. 19, 2019 /PRNewswire/ -- Physicians should attempt to maintain full doses of chemotherapy, especially early in the treatment course, for intermediate or high risk breast cancer patients, according to new research published in the August 2019 issue of

BEVERLY, Mass., Aug. 19, 2019 /PRNewswire/ -- Boss Pet Products, Inc. and PetEdge LLC, a leading supplier of wholesale pet products and grooming supplies, is pleased to announce the launch of an innovative aromatherapy product for dogs - ikaria® PetScent Clips™ that turn any dog collar into a calming and soothing collar.

DALLAS, Aug. 19, 2019 /PRNewswire/ -- Executives from CirrusMD, GreatCall, Livongo Health, Philips, and UnitedHealthcare will deliver the keynotes at Parks Associates' sixth annual

SCHAFFHAUSEN, Switzerland, Aug. 19, 2019 /PRNewswire/ -- TE Connectivity Ltd. (NYSE: TEL), a global leader in connectivity and sensors, has been ranked fourth of 52 large companies from around the world on the 2019

AIRFLOW-2 randomized, sham-controlled one-year data accepted by AJRCCM   MINNEAPOLIS, Aug. 19, 2019 /PRNewswire/ -- Nuvaira, a developer of novel therapeutic strategies to tr

Phase 2 Expansion More Than Doubles Company's Florida Cultivation Output MIAMI, FL, Aug. 19, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it has begun growing in

Dr. Wolfgang Renz, Chief Medical Officer, takes on additional responsibilities as Regional Manager Europe VANCOUVER, Aug. 19, 2019 /PRNewswire/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) is pleased to announce today that its board of directors has appointed

PLYMOUTH MEETING, Pa., Aug. 19, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has completed enrollment in the company's open-label, 24 patient, Phase 2 trial with its lead immunotherapy product VGX-3100 in patients with precancerous lesions of the anus, i.e. anal high-grade squamous intraepithelial lesions (anal HSIL, aka anal i

BOSTON, Aug. 19, 2019 /PRNewswire/ -- On October 18, 2019, thousands of people across the U.S. will show their support for those affected by cancer and raise money for cancer charities as a part of National